2025-2026 Regular Session
HF3609
Disallowance of drug manufacturers from restricting delivery of 340B prescription drugs continued, enforcement provided, and expiration date removed.
Legislative progress
i
This summary includes only completed milestones supported by recorded actions. It does not predict the next step, and it preserves later committee reassignments, concurrence, conference, veto, and approval actions when they occur.
Introduced in House February 23, 2026
Recorded floor votes
1 roll call are available for this bill. This record includes procedural and intermediate action as well as substantive final votes.
March 23, 2026 · House
House: Bierman motion Recall and Re-refer
Failed
67 yea–67 nay
Committee referrals
February 23, 2026 · House
Health Finance & Policy
Instrument history
i
This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.
-
House Author added Repinski
-
House Author added Baker
-
House Author stricken Schomacker
-
House Motion to recall and re-refer, motion did not prevail Commerce Finance and Policy
-
House Author added Keeler
-
House Author added Anderson, P. H.
-
House Authors added Warwas, Skraba, and Davis
-
House Author stricken Perryman
-
House Author added Gander
-
House Author added Rehrauer
-
House Authors added Norris, Johnson, P., and Swedzinski
-
House Author stricken Gillman
-
House Introduction and first reading, referred to Health Finance and Policy